Skip to main content

Table 3 Concentrations of Apo A1, A2, B, C3, E, H and J in the plasma of the diabetic patients divided by GFR

From: Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients

 

RD

SlD

N

p value

Apo A1 (ng/mL)

4.289e+006 (1.752e+006)

4.653e+006 (1.715e+006)

4.925e+006 (2.021e+006)

0.7427

Apo A2 (ng/mL)

184,582 (47,323)

237,641 (177,992)

167,090 (66,080)

0.7145

Apo B (ng/mL)

1.528e+006 (137,227)

1.486e+006 (104,370)

1.537e+006 (100,729)

0.5790

Apo C3 (ng/mL)

66,449 (20,720)

73,448 (48,535)

56,741 (29,542)

0.6600

Apo E (ng/mL)

32,008 (14,590)

38,629 (9,400)

37,414 (7,629)

0.3682

Apo H (ng/mL)

164,944 (32,147)

182,433 (95,217)

129,301 (46,866)

0.1048

Apo J (ng/mL)

137,605 (17,021)

139,465 (29,007)

136,150 (22,101)

0.9502

  1. Numbers are presented as mean (SD)